₹5,644 Cr
₹376 Cr
15.02
As on 30-May-2023 IST
₹7.50
•
1.02%
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Caplin Point Laboratories
| 4.22 | 9.60 | 12.08 | 1.47 | 32.41 | 6.71 | -- |
|
S&P BSE Healthcare
| 2.15 | 2.15 | 7.91 | 4.71 | 14.57 | 12.23 | 10.13 |
|
S&P BSE Small Cap
| 4.81 | 4.85 | 11.34 | 18.34 | 40.67 | 11.77 | 17.47 |
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
|---|---|---|---|---|---|---|---|
|
Caplin Point Laboratories
| -16.88 | 69.91 | 71.89 | -21.39 | -39.75 | 84.02 | 23.58 |
|
S&P BSE Small Cap
| -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 | 1.77 |
|
S&P BSE Healthcare
| -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 | -12.88 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
₹5,644.02 Cr
₹1,466.73 Cr
₹376.25 Cr
₹652.65 Cr
₹0.50 Cr
70.66%
High
₹575.00 - 856.80
₹2.00
7,59,21,746
BSE: 524742, NSE: CAPLIPOINT
Chennai, Tamil Nadu
www.caplinpoint.net
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic droppers, prefilled bags, tablets, dry... syrups, soft gels, capsules, suppositories, liquid syrups in bottles, liquid injectables in ampoules and vials, prefilled syringes, emulsion injection in ampoules and vials, topicals, and sachets. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India. Read more
Share via Facebook 
Share via Twitter 
Share via LinkedIn 
Share this
Add Portfolio